Takeda takes healthy bite out of Shire takeover requirement

Nigel Owen

November 15, 2018 03:30 pm

Takeda — A signboard of Takeda Pharmaceutical Co., Ltd. on display outside its building in Tokyo on October 3, 2018, Japan. (Photo by Rodrigo Reyes Marin/AFLO) | Rodrigo Reyes Marin/AFLO/Press Association Images

Japanese pharmaceuticals company Takeda implemented the first part of its financing of a £46bn takeover of UK biotech firm Shire on Thursday. The company used a six tranche combination to raise €7.5bn on its debut in the euro market.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

JP Morgan Bank of America Barclays Corporate Bonds Sumitomo Mitsui Financial Group Japan Mizuho Morgan Stanley Northeast Asia BNP Paribas News content MUFG Asia Pacific Euro HSBC Asia

NO

Nigel Owen